Virological outcomes and adherence to treatment algorithms in a longitudinal study of patients with chronic hepatitis C treated with boceprevir or telaprevir in the U.S. (HCV-TARGET) - Di Bisceglie, A; Kuo, A; Rustgi, V; Sulkowski, M
Paper presented at: AASLD The Liver Meeting; November 1–5, 2013; Washington, DC